We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Sensus Healthcare, Inc. (SRTS) Declines More Than Market: Some Information for Investors
Read MoreHide Full Article
Sensus Healthcare, Inc. (SRTS - Free Report) closed at $4.64 in the latest trading session, marking a -2.11% move from the prior day. This change lagged the S&P 500's daily loss of 0.11%. Elsewhere, the Dow gained 0.91%, while the tech-heavy Nasdaq lost 0.82%.
Shares of the company have appreciated by 0.42% over the course of the past month, underperforming the Medical sector's gain of 1.66%, and the S&P 500's gain of 5.17%.
Investors will be eagerly watching for the performance of Sensus Healthcare, Inc. in its upcoming earnings disclosure. In that report, analysts expect Sensus Healthcare, Inc. to post earnings of $0.01 per share. This would mark a year-over-year decline of 90%. In the meantime, our current consensus estimate forecasts the revenue to be $8.8 million, indicating a 4.76% decline compared to the corresponding quarter of the prior year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $0.11 per share and a revenue of $41.95 million, signifying shifts of -73.17% and +0.34%, respectively, from the last year.
Investors might also notice recent changes to analyst estimates for Sensus Healthcare, Inc. These recent revisions tend to reflect the evolving nature of short-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Sensus Healthcare, Inc. currently has a Zacks Rank of #5 (Strong Sell).
In terms of valuation, Sensus Healthcare, Inc. is presently being traded at a Forward P/E ratio of 43.09. This expresses a premium compared to the average Forward P/E of 27.15 of its industry.
The Medical - Instruments industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 181, finds itself in the bottom 27% echelons of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Sensus Healthcare, Inc. (SRTS) Declines More Than Market: Some Information for Investors
Sensus Healthcare, Inc. (SRTS - Free Report) closed at $4.64 in the latest trading session, marking a -2.11% move from the prior day. This change lagged the S&P 500's daily loss of 0.11%. Elsewhere, the Dow gained 0.91%, while the tech-heavy Nasdaq lost 0.82%.
Shares of the company have appreciated by 0.42% over the course of the past month, underperforming the Medical sector's gain of 1.66%, and the S&P 500's gain of 5.17%.
Investors will be eagerly watching for the performance of Sensus Healthcare, Inc. in its upcoming earnings disclosure. In that report, analysts expect Sensus Healthcare, Inc. to post earnings of $0.01 per share. This would mark a year-over-year decline of 90%. In the meantime, our current consensus estimate forecasts the revenue to be $8.8 million, indicating a 4.76% decline compared to the corresponding quarter of the prior year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $0.11 per share and a revenue of $41.95 million, signifying shifts of -73.17% and +0.34%, respectively, from the last year.
Investors might also notice recent changes to analyst estimates for Sensus Healthcare, Inc. These recent revisions tend to reflect the evolving nature of short-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Sensus Healthcare, Inc. currently has a Zacks Rank of #5 (Strong Sell).
In terms of valuation, Sensus Healthcare, Inc. is presently being traded at a Forward P/E ratio of 43.09. This expresses a premium compared to the average Forward P/E of 27.15 of its industry.
The Medical - Instruments industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 181, finds itself in the bottom 27% echelons of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.